# Executive Summary — Phase 6 — Personal US30 Capital Plan with Compound Growth

The personal backtest on US30 (`2026-04_Quantum_US30_SingleTrader`) covers 6+ years of operation (August 2019 – April 2026) with 1,823 closed trades in a personal account. The analysis confirms a positive quantitative edge: `expectancy = 181.70`, `profit_factor = 1.564`, `SQN ≈ 4.700` and `max_drawdown_approx = 14.47%`.

The capital management plan is defined as personal trading with compound growth: capital grows with each profitable cycle and position size is adjusted proportionally to available capital. This maximizes the growth curve in favorable scenarios and automatically reduces exposure during drawdowns, without manual intervention for each size adjustment.

The continuity thesis is **positive but conditional**. The edge is statistically defensible, but structural reservations exist: open data quality warning (timezone and surrogate trader_id), total concentration in US30, and a dominant BUY/SELL directional bias (75.5% / 24.5%). These reservations do not invalidate the strategy, but require active monitoring.

Therefore, the plan is approved as **controlled operation with periodic review**, with explicit continuity rules (hard limits), a quantitative baseline profile, weekly/monthly/quarterly monitoring, and a complementary ML module for drift detection. The compound growth projection is recalibrated quarterly to reflect current capital and observed edge consistency.
